Investor uproar | Has AstraZeneca's CEO proven that exec pay is out of control?

The morality of executive pay is very much one of the key workplace battles of our time; throughout the pandemic, many major firms such as Co-op and Foxtons have garnered a wealth of criticism for the morality of offering bonuses to bosses despite furloughing staff throughout the pandemic.

Now, pharma giant AstraZeneca, responsible for the production of one of the most widely available coronavirus vaccines, has found itself at the centre of an executive pay scandal.